Prokidney Corp. has 5 Schedule 13D or 13G filings on record since 2025-07-17. 1 holder's latest filing reports 5% or more of class a common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Control Empresarial de Capitales S.A. de C.V. | 36% | 73,842,723 | SCHEDULE 13D/A, 2026-04-30 | 2026-04-28 |
| Morgan Stanley | 4.7% | 9,653,756 | SCHEDULE 13G/A, 2026-08-12 | 2026-06-30 |
| BlackRock, Inc. | 1.4% | 1,764,602 | SCHEDULE 13G/A, 2025-07-17 | 2025-06-30 |
Purpose of Transaction (Item 4)
Control Empresarial de Capitales S.A. de C.V.
Delaware Domestication On July 1, 2025, the Issuer effected a domestication from the Caymans Islands to the State of Delaware (the "Domestication"). Effective as of July 1, 2025, each (i) Class A ordinary share automatically converted into one share of Class A Common Stock of the Issuer and (ii) each Class B ordinary share automatically converted into one share of Class B common stock of the Issuer. Exchange Agreement Prior to April 28, 2026 (the "Transaction Date"), in addition to 10,724,078 shares of Class A Common Stock, the Reporting Persons beneficially owned 63,118,645 shares of Class B common stock of the Issuer held by Control Empresarial, each of which may, subject to the limitations set forth in the Amended and Restated Exchange Agreement and the Holdings LLCA (each as defined and as described in the Issuer's Current Report on Form 8-K filed with the SEC on July 3, 2025), be exchanged, together with the paired common unit in ProKidney Holdings, LLC (the "Paired Interests"), for a share of Class A Common Stock on a one-for-one basis. Control Empresarial held 63,118,645 Paired Interests prior to the Transaction Date. On the Transaction Date, Control Empresarial exchanged 63,118,645 Paired Interests for 63,118,645 shares of Class A Common Stock. As a result, as of the date of this filing, the Reporting Persons beneficially own 73,842,723 shares of Class A Common Stock.Item 4 of the SCHEDULE 13D/A filed 2026-04-30
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-17 | BlackRock, Inc. | 1.4% | SCHEDULE 13G/A |
| 2025-08-07 | Morgan Stanley | 4.4% | SCHEDULE 13G/A |
| 2026-02-12 | Morgan Stanley | 6% | SCHEDULE 13G |
| 2026-04-30 | Control Empresarial de Capitales S.A. de C.V. | 36% | SCHEDULE 13D/A |
| 2026-08-12 | Morgan Stanley | 4.7% | SCHEDULE 13G/A |
Tools for this story
Each opens in a new tab, filled in for Prokidney Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.